PRINCETON, N.J.—Peter J. Mariani, the Chief Financial Officer of Cytosorbents Corp (NASDAQ:), recently acquired a substantial amount of the company's common stock. According to a recent SEC filing, Mariani purchased 20,000 shares on December 13, 2024, at an average price of $0.9647 per share. This transaction amounted to a total value of $19,294. The purchase comes as the stock shows strong momentum, with InvestingPro data showing a 14.75% gain over the past week. The company, currently valued at approximately $55 million, has caught analysts' attention with price targets ranging from $1 to $10 per share.

The shares were bought in open market transactions at varying prices ranging from $0.8902 to $1.09. Following this purchase, Mariani now directly owns 401,363 shares of Cytosorbents, which includes restricted stock units (RSUs) that are subject to vesting conditions. According to InvestingPro, the company's current price represents a significant discount to its Fair Value, suggesting potential upside opportunity. Subscribers can access additional insights, including 6 more ProTips and a comprehensive Pro Research Report, which provides deep-dive analysis of CTSO's financial health and growth prospects.

In other recent news, CytoSorbents Corporation has announced the terms of an upcoming Rights Offering, aiming to raise between $3.0 million and $5.0 million. This move could potentially double the liquidity for the company,...